Evaluating the efficacy of N-acetylcysteine in diminishing the duration and frequency of rotavirus-induced gastroenteritis: a preliminary randomized, placebo-controlled, double-blind clinical trial.
- 2025-03-12
- RCT · n = 71
- BMC pediatrics 25(1)
- Behrooz Heydari
- Majid Aflatonian
- Mina Bagherizadeh
- Farahnaz Hoseinzade
- Fatemeh Saghafi
- PubMed: 40069676
- DOI: 10.1186/s12887-025-05534-7
- High evidence
- Clinical
During the diarrhea period, the number of bowel movements in the NAC group was recorded at 28.1 ± 21.6 times, whereas in the placebo group, it was 35.3 ± 33.1 times, yielding a p-value of 0.409.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 60 mg/kg/day